cns.jpg (2811 bytes)

Subscription

Reprints

Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates


© Neva Press, Inc. 2005


CNS Drug Reviews

Table of Contents

Volume 4, No. 3

Reviews
201 E-5842:  A New Potent and Preferential Sigma Ligand.  Preclinical Pharmacological Profile
X. Guitart, X. Codony, M. Ballarin, A. Dordal and A. J. Farré
[Article]
225 Preclinical and Pharmacological Studies of AG284, a Soluble HLA-DR2:Myelin Basic Protein Peptide Complex for the Treatment of Multiple Sclerosis
Edward G. Spack, Nancy G. Wehner and Jeffrey L. Winkelhake
[Article]
247 Ipidacrine (NIK-247):  A Review of Multiple Mechanisms as an Antidementia Agent
Jun Kojima, Kenji Onodera, Mitsuo Ozeki and Kunio Nakayama
[Article]
260 Vigabatrin
Raman Sankar and Aline T. Derdiarian
[Article]
Meeting Reports
275 The 21st Annual Meeting of the Canadian College of Neuropsychopharmacology.  Montreal, Canada.   June 14-17, 1998.
L. K. Srivastava, J. Rochford and S. N. Young
[Article]
287 XIIIth International Congress of Pharmacology.  New Drugs Affecting Central Nervous System.   Munich, Germany.  July 26-31, 1998.
A. Scriabine
[Article]
291 Nucleotides and Their Receptors in the Nervous System.  Leipzig, Germany.  August 1-2, 1998.
Laszlo Köles
[Article]
301 The 7th Biennial Meeting of the European Behavioral Pharmacology Society (EBPS '98), a Joint Meeting with the Behavioral Pharmacology Society.  Brno, Czech Republic.   September 2-6, 1998.
Alexandra E. Sulcova
[Article]